RESUMEN
To evaluate the effect of lactulose on calcium (Ca) and magnesium (Mg) absorption, we performed a clinical trial with a double-blind, randomized, crossover design in 24 healthy adult male volunteers. The absorptions of Ca and Mg were evaluated by a single-labeling method using stable isotopes. The test foods, containing lactulose at a dose of 0 g (placebo), 2 g (low-dose), or 4 g (high-dose) together with 300 mg of Ca containing 20 mg of 44Ca, and 150 mg of Mg containing 28 mg of 25Mg, were administered orally. Urine samples were collected for 8 h after the ingestion of the test food. The ratios of stable isotopes in urine (44Ca/40Ca and 25Mg/24Mg) were measured by ICP-MS (inductively coupled plasma-mass spectrometry). The urinary stable-isotopes ratios (44Ca/40Ca and 25Mg/24Mg) increased with lactulose dosage. Significant differences were observed in the Ca ratio between placebo and high-dose lactulose (p<0.01), and in the Mg ratio between placebo and low-dose lactulose and between placebo and high-dose lactulose (p<0.01). Lactulose ingestion did not change the levels of bone-resorption markers (type I collagen cross-linked N-telopeptide and deoxypyridinoline) in urine. The test foods did not cause any side effects. This study demonstrates that lactulose enhances the absorptions of Ca and Mg in adult men.
Asunto(s)
Calcio/administración & dosificación , Calcio/metabolismo , Fármacos Gastrointestinales/administración & dosificación , Absorción Intestinal/efectos de los fármacos , Lactulosa/administración & dosificación , Magnesio/administración & dosificación , Magnesio/metabolismo , Adulto , Aminoácidos/efectos de los fármacos , Aminoácidos/orina , Análisis de Varianza , Biomarcadores/sangre , Biomarcadores/orina , Remodelación Ósea/efectos de los fármacos , Calcio/orina , Isótopos de Calcio/administración & dosificación , Isótopos de Calcio/orina , Colágeno Tipo I/efectos de los fármacos , Colágeno Tipo I/orina , Creatinina/orina , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Ensayo de Inmunoadsorción Enzimática , Humanos , Magnesio/orina , Masculino , Espectrometría de Masas , Péptidos/efectos de los fármacos , Péptidos/orina , Valores de ReferenciaRESUMEN
The immunostimulatory oligodeoxynucleotide (ODN) BL07 (5'-GCGTCGGTTTCGGTGCTCAC-3') was identified from the genomic DNA of the probiotic strain Bifidobacterium longum BB536. ODN BL07 stimulated B-lymphocyte proliferation and induced interleukin-12 (IL-12) production in macrophage-like J774.1 cells. ODNs BL07 and BL07S (modified with phosphorothioate backbone) significantly inhibited immunoglobulin E (IgE) production and stimulated interferon-gamma (IFN-gamma) and IL-12 production, but did not affect IL-4 secretion in murine splenic cells of ovalbumin-primed BALB/c mice. These ODNs also significantly inhibited production of IgE in purified murine B cells in the presence of IL-4 and anti-CD40. The results suggest the potential of ODNs BL07 and BL07S in preventing IgE-related immune responses and the possible involvement of ODN BL07 in the antiallergic efficacy of B. longum BB536.
Asunto(s)
Bifidobacterium/genética , Bifidobacterium/inmunología , ADN Bacteriano/inmunología , Inmunoglobulina E/biosíntesis , Oligodesoxirribonucleótidos/genética , Probióticos/farmacología , Animales , Linfocitos B/citología , Linfocitos B/inmunología , Secuencia de Bases , Proliferación Celular , ADN Bacteriano/química , ADN Bacteriano/genética , Ensayo de Inmunoadsorción Enzimática , Inmunoglobulina E/inmunología , Isotipos de Inmunoglobulinas/inmunología , Interferón gamma/inmunología , Interleucina-12/inmunología , Interleucina-4/inmunología , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , FN-kappa B/inmunología , Oligodesoxirribonucleótidos/inmunología , Oligodesoxirribonucleótidos/aislamiento & purificación , Análisis de Secuencia de ADN , Organismos Libres de Patógenos EspecíficosRESUMEN
The addition of a compound that lowers the intestinal uptake of fat and cholesterol might be an interesting strategy to reduce the risk of vascular disease. Partially hydrolyzed guar gum (PHGG) has been shown to have this effect in healthy volunteers after intake of a yogurt drink with 3 to 6% PHGG. In the present study a yogurt drink with 3% sunflower oil and 4% egg yolk was tested with 3% and 6% PHGG, and compared to a control without PHGG. Experiments were performed in a multi-compartmental model of the gastrointestinal tract, equipped to study the digestion and availability for absorption (bioaccessibility) of lipids. The results show that PHGG decreases the bioaccessibility of both fat and cholesterol in a dose-dependent manner. The bioaccessibility of fat was 79.4+/-1.7%, 70.8+/-2.5% and 60.1+/-1.1% for the control experiments and the experiments with 3% and 6% PHGG respectively. The bioaccessibility of cholesterol was 82.2+/-2.0%, 75.4+/-1.2% and 64.0+/-4.3% for the control and the experiments with 3% and 6% PHGG respectively. Additional experiments indicated that PHGG reduces bioaccessibility through the depletion flocculation mechanism. Depletion flocculation antagonizes the emulsification by bile salts and thus decreases lipolytic activity, resulting in a lower bioaccessibility of fat and cholesterol. Depletion flocculation with polymers might be an interesting mechanism, not described before, to reduce fat and cholesterol absorption.
Asunto(s)
Colesterol en la Dieta/análisis , Grasas de la Dieta/análisis , Galactanos/farmacología , Mananos/farmacología , Modelos Biológicos , Bilis , Galactanos/química , Concentración de Iones de Hidrógeno , Hidrólisis , Absorción Intestinal/efectos de los fármacos , Mananos/química , Micelas , Valor Nutritivo , Pepsina A , Gomas de Plantas , Aceites de Plantas , Aceite de Girasol , Factores de Tiempo , YogurRESUMEN
Acidity is an environmental condition commonly encountered by lactic acid bacteria and bifidobacteria in the gastrointestinal tract and fermented foods. In the present study, 22 strains of Bifidobacterium were screened for acid tolerance in artificial gastric juice (AGJ, pH 3.0) and fermented milk. AGJ tolerance was found to be strain-specific, with a pronounced variation among the strains. Several strains with a high survival rate in AGJ that belonged to Bifid. longum, Bifid. breve and Bifid. adolescentis were selected. Among them, only strain BL1 of Bifid longum was found to possess a high survival rate in fermented milk during refrigerated storage. Strain BL1 exhibited a survival rate of more than 25% in AGJ at pH 3.0 for 2 h and maintained a viable cfu level of more than 10(8) per gram of product in fermented milk (pH 4.6) under refrigerated conditions for 2 weeks. The acid tolerance of strain BL1 was found to depend on the final growth pH (<4.5). Rapid loss of acid tolerance was observed when the cells were shifted from acid to neutral conditions by addition of NaOH. Strain BL1 cells were able to maintain much higher intracellular pH under acid conditions, in comparison with those of AGJ sensitive mutant (BL1-S) or cells that lost acid tolerance following pH shifting from acid to neutral conditions. These results suggested that a cytoplasmic pH homeostasis system may function in the acid tolerance response in this strain.
Asunto(s)
Bifidobacterium/genética , Bifidobacterium/fisiología , Selección Genética , Animales , Frío , Fermentación , Jugo Gástrico/microbiología , Homeostasis , Concentración de Iones de Hidrógeno , Leche/microbiologíaRESUMEN
This study assessed the effect of partially hydrolyzed guar gum (PHGG) in yogurt on the elevation of postprandial serum lipid levels. Eleven healthy adult male subjects were given yogurt with or without 6 g of PHGG in a fat tolerance test as a crossover study. Supplementation with 6 g of PHGG significantly suppressed the incremental peaks and areas under the incremental curve (AUIC) of postprandial serum remnant-like lipoprotein particle cholesterol (RLP-C) and triglyceride (TG). The results suggest the potential of PHGG to reduce the risk of hyperlipemia.
Asunto(s)
Fibras de la Dieta/administración & dosificación , Galactanos/administración & dosificación , Lípidos/sangre , Mananos/administración & dosificación , Periodo Posprandial/efectos de los fármacos , Yogur , Adulto , Humanos , Masculino , Persona de Mediana Edad , Gomas de PlantasRESUMEN
Stable anhydrous lactulose was produced from lactulose trihydrate by stepwise heating on a fluidized bed. The processes were performed on stable powder forms. The anhydrous lactulose was characterized by an opaque white appearance, a coarse surface structure with random cracks and indentations, a high degree of crystallization, stability under humid conditions, and by X-ray powder diffraction, differential thermal analysis, and differential thermogravimetry. Those characteristics were different from those of the original trihydrate, which was transparent, had a smooth surface and a higher degree of crystallization, was stable under humid conditions and had different X-ray powder diffraction, differential thermal analysis, and thermogravimetric characteristics. The transformation was enhanced when the inlet temperature was 45-55 degrees C or when the temperature of the fluidized bed was over 40 degrees C. At these cutoff temperatures, both crystalline forms were observed.